I love to kick off the new trading week by taking a quick peek at companies that have just hiked their dividends. It's not just about the money; a company that is easing up on its pocketbook probably has improving fundamentals to back up that generosity.
Readers of the Income Investor newsletter can certainly appreciate that kind of thinking. Let's take a closer look at four of the companies that inched their payouts higher over the past week.
We'll start with Pfizer
With the sector presently out of favor, Pfizer and Eli Lilly are yielding a beefy 5.5% and 3.5% respectively. Wow. Pfizer is at 5.5%! That's more than twice the yield of rivals like Merck
Finally, we have Waste Management
Subscribers to the Income Investor newsletter can appreciate the companies sending more and more money to their investors. The newsletter singles out companies that are committed to growing their distributions with market-thumping results.
Want to see what's being recommended these days? Go ahead and give the newsletter service a shot with a 30-day trial subscription. Who knows? Maybe the next thing to get hiked will be your interest.
Longtime Fool contributor Rick Munarriz pays attention to yield signs. He does not own shares in any of the companies in this story. He is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early. The Fool has a disclosure policy.